MannKind Corp. (MNKD)
5.90
-0.01
(-0.17%)
USD |
NASDAQ |
Feb 10, 10:22
MannKind EPS Diluted (Quarterly) : 0.0256 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Keros Therapeutics, Inc. | -0.1792 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.985M |
| Revenue (Quarterly) | 82.13M |
| Total Expenses (Quarterly) | 74.14M |
| Enterprise Value | 1.781B |
| Gross Profit Margin (Quarterly) | 75.40% |
| Profit Margin (Quarterly) | 9.72% |
| Earnings Yield | 1.60% |
| Operating Earnings Yield | 4.19% |
| Normalized Earnings Yield | 2.388 |